Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
1.855.MyBioSource
Fax 1.858.633.0166    Email sales@mybiosource.com 
tel/fax
menu1 Home Products Ordering Company Help menu7
bottom
   MyBioSource  rightarrow Protein Family  rightarrow Short-chain dehydrogenase  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Menu separator
separator
ELISA Kit ELISA Kit
CLIA Kit CLIA Kit
PCR Kit PCR Kit
Monoclonal Antibody Monoclonal Antibody
Polyclonal Antibody Polyclonal Antibody
Secondary Antibody Secondary Antibody
Antigen Antigen
Biochemical Biochemical
cDNA Clone cDNA Clone
siRNA siRNA
Peptide Peptide
Recombinant/Purified Protein Rec./Purified Protein

Custom ELISA Kit Custom ELISA Kit
Custom Protein Custom Protein
Custom Antibody Custom Antibody
Antibody Matched Pairs Antibody Matched Pairs
Antibody & Corresponding Blocking Peptide Pairs Antibody Peptide Pairs
Phospho-Specific Antibodies Phospho Antibodies
Products by Disease Products by Disease
Products by Pathway Products by Pathway
Products by Tissue Products by Tissue

arrow Advanced Search
arrow Submit Technical Q&A
arrow International Distributors
arrow Contact Us
separator
Our Best Sellers moreseparator
separator
 • Caspase 8 (Cleaved-Asp384) (CASP8) Antibody
 • SHC3 Antibody
 • C-EBP-alpha (Phospho-Thr230) Antibody
 • DDX51 Antibody
 • Neuronal Nuclear Autoantibody 2 (ANNA2) ELISA Kit
 • Epithelial Cell Adhesion Molecule (EPCAM) ELISA Kit
 • Activating Transcription Factor 6 (ATF6) ELISA Kit
 • B-Cell Cll-Lymphoma 3 (BCL3) ELISA Kit
 • Acetylcholine Receptor Antibody (ACHRAB) ELISA Kit
 • Growth Differentiation Factor 3 (GDF3) ELISA Kit
 • Stem Cell Factor (SCF) ELISA Kit
 • Nucleoporin 205Kda (NUP205) ELISA Kit
 • Protein Phosphatase (PP) ELISA Kit
 • Vitamin B1 (VB1) ELISA Kit
 downarrow more ...
separator

Short-chain dehydrogenase

separator
Involved in protein precursor import into chloroplasts. Part of the redox regulon consisting of TIC32, TIC 55 and TIC62.

Below are the list of possible Short-chain dehydrogenase products. If you cannot find the target and/or product is not available in our catalog, please click here to contact us and request the product or submit your request for custom elisa kit production, custom recombinant protein production or custom antibody production. Custom ELISA Kits, Recombinant Proteins and Antibodies can be designed, manufactured and produced according to the researcher's specifications.
 

Short chain dehydrogenase andC

 Short chain dehydrogenase andC ELISA Kit
 Short chain dehydrogenase andC Recombinant
 Short chain dehydrogenase andC Antibody
Also known as Short chain dehydrogenase andC (Anditomin synthesis protein C).
Short chain dehydrogenase; part of the gene cluster that mediates the biosynthesis of anditomin, a fungal meroterpenoid (PubMed:25216349). The first step of the pathway is the synthesis of 3,5-dimethylorsellinic acid (DMOA) by the polyketide synthase andM (PubMed:25216349). DMOA is then converted to the phthalide comp
>>>
ound 5,7-dihydroxy-4,6-dimethylphthalide (DHDMP) by the cytochrome P450 monooxygenase andK, which is further prenylated by the prenyltransferase andD to yield farnesyl-DHDMP (PubMed:25216349). Further epoxidation by the FAD-dependent monooxygenase andE leads to epoxyfarnesyl-DHDMP (PubMed:25216349). The next step involves the terpene cyclase andB that converts epoxyfarnesyl-DHDMP into preandiloid A through opening of the epoxide ring followed by the cyclization of the farnesyl moiety (PubMed:25216349). Preandiloid A is in turn oxidized at the C-3 hydroxyl group to yield preandiloid B by the dehydrogenase andC (PubMed:25216349). The dioxygenase andA is solely responsible for the dehydrogenation of preandiloid B leading to the enone preandiloid C, as well as for the intriguing structural rearrangement to generate the bicyclo[2.2.2]octane core, transforming preandiloid C into andiconin (PubMed:25216349). FAD-binding monooxygenase andJ then produces andilesin D which is reduced by dehydrogenase andI to yield andilesin A (PubMed:25216349). Action of acetyltransferase andG followed by a spontaneous acetate elimination leads then to andilesin B, which is in turn substrate of the short chain dehydrogenase andH to yield andilesin C (PubMed:25216349). Finally, the dioxygenase andF catalyzes the transformation of andilesin C to anditomin (PubMed:25216349).
 andC ELISA Kit
 andC Recombinant
 andC Antibody
Table BarTOPTable Bar
 

Short chain dehydrogenase andI

 Short chain dehydrogenase andI ELISA Kit
 Short chain dehydrogenase andI Recombinant
 Short chain dehydrogenase andI Antibody
Also known as Short chain dehydrogenase andI (Anditomin synthesis protein I).
Short chain dehydrogenase; part of the gene cluster that mediates the biosynthesis of anditomin, a fungal meroterpenoid (PubMed:25216349). The first step of the pathway is the synthesis of 3,5-dimethylorsellinic acid (DMOA) by the polyketide synthase andM (PubMed:25216349). DMOA is then converted to the phthalide comp
>>>
ound 5,7-dihydroxy-4,6-dimethylphthalide (DHDMP) by the cytochrome P450 monooxygenase andK, which is further prenylated by the prenyltransferase andD to yield farnesyl-DHDMP (PubMed:25216349). Further epoxidation by the FAD-dependent monooxygenase andE leads to epoxyfarnesyl-DHDMP (PubMed:25216349). The next step involves the terpene cyclase andB that converts epoxyfarnesyl-DHDMP into preandiloid A through opening of the epoxide ring followed by the cyclization of the farnesyl moiety (PubMed:25216349). Preandiloid A is in turn oxidized at the C-3 hydroxyl group to yield preandiloid B by the dehydrogenase andC (PubMed:25216349). The dioxygenase andA is solely responsible for the dehydrogenation of preandiloid B leading to the enone preandiloid C, as well as for the intriguing structural rearrangement to generate the bicyclo[2.2.2]octane core, transforming preandiloid C into andiconin (PubMed:25216349). FAD-binding monooxygenase andJ then produces andilesin D which is reduced by dehydrogenase andI to yield andilesin A (PubMed:25216349). Action of acetyltransferase andG followed by a spontaneous acetate elimination leads then to andilesin B, which is in turn substrate of the short chain dehydrogenase andH to yield andilesin C (PubMed:25216349). Finally, the dioxygenase andF catalyzes the transformation of andilesin C to anditomin (PubMed:25216349).
 andI ELISA Kit
 andI Recombinant
 andI Antibody
Table BarTOPTable Bar
 

Short chain dehydrogenase asqE

 Short chain dehydrogenase asqE ELISA Kit
 Short chain dehydrogenase asqE Recombinant
 Short chain dehydrogenase asqE Antibody
Also known as Short chain dehydrogenase asqE (4'-methoxyviridicatin/aspoquinolone biosynthesis cluster protein asqE) (Aspoquinolone biosynthesis protein E).
Short chain dehydrogenase; part of the gene cluster that mediates the biosynthesis of the aspoquinolone mycotoxins (PubMed:25251934). The first stage is catalyzed by the nonribosomal pepdide synthetase asqK that condenses anthranilic acid a
>>>
nd O-methyl-L-tyrosine to produce 4'-methoxycyclopeptin (PubMed:25251934). AsqK is also able to use anthranilic acid and L-phenylalanine as substrates to produce cyclopeptin, but at a tenfold lower rate (PubMed:25251934). 4'-methoxycyclopeptin is then converted to 4'-methoxydehydrocyclopeptin by the ketoglutarate-dependent dioxygenase asqJ through dehydrogenation to form a double bond between C-alpha and C-beta of the O-methyltyrosine side chain (PubMed:25251934). AsqJ also converts its first product 4'-methoxydehydrocyclopeptin to 4'-methoxycyclopenin (PubMed:25251934). AsqJ is a very unique dioxygenase which is capable of catalyzing radical-mediated dehydrogenation and epoxidation reactions sequentially on a 6,7-benzo-diazepinedione substrate in the 4'-methoxyviridicatin biosynthetic pathway (PubMed:25251934). The following conversion of 4'-methoxycyclopenin into 4'-methoxyviridicatin proceeds non-enzymatically (PubMed:25251934). AsqJ is also capable of converting cyclopeptin into dehydrocyclopeptin and cyclopenin in a sequential fashion (PubMed:25251934). Cyclopenin can be converted into viridicatin non-enzymatically (PubMed:25251934). 4'-methoxyviridicatin likely acts as a precursor of quinolone natural products, such as aspoquinolones, peniprequinolones, penigequinolones, and yaequinolones (PubMed:25251934). Further characterization of the remaining genes in the cluster has still to be done to determine the exact identity of quinolone products this cluster is responsible for biosynthesizing (PubMed:25251934).
 asqE ELISA Kit
 asqE Recombinant
 asqE Antibody
 AN9232 ELISA Kit
 AN9232 Recombinant
 AN9232 Antibody
Table BarTOPTable Bar
 

Short chain dehydrogenase gsfE

 Short chain dehydrogenase gsfE ELISA Kit
 Short chain dehydrogenase gsfE Recombinant
 Short chain dehydrogenase gsfE Antibody
Also known as Short chain dehydrogenase gsfE (Griseofulvin synthesis protein E).
Short chain dehydrogenase; part of the gene cluster that mediates the biosynthesis of griseofulvin, an important antifungal drug that has been in use for a long time for treating dermatophyte infections (PubMed:20534346, PubMed:23978092). The first step of the pathway is the formation of the heptaketide backbone by
>>>
gsfA which is initiated by priming with acetyl-CoA, followed by sequential condensations of 6 malonyl-CoA units (PubMed:20534346). O-methylation at 3-OH by gsfB leads to griseophenone D which is further methylated at 9-OH by gsfC to yield griseophenone C (PubMed:23978092). Griseophenone C is then substrate of halogenase gsfI which is responsible for the regio-specific chlorination at the C13 position to form griseophenone B (PubMed:23978092). The cytochrome P450 gsfF catalyzes the coupling of orcinol and phloroglucinol rings in griseophenone B to form desmethyl-dehydrogriseofulvin A which is further methylated at 5-OH by gsfD to yield dehydrogriseofulvin (PubMed:23978092). Finally, gsfE performs stereospecific reduction of enone 18 of dehydrogriseofulvin to afford the final product griseofulvin (PubMed:23978092).
 gsfE ELISA Kit
 gsfE Recombinant
 gsfE Antibody
Table BarTOPTable Bar
 

Short chain dehydrogenase gsfK

 Short chain dehydrogenase gsfK ELISA Kit
 Short chain dehydrogenase gsfK Recombinant
 Short chain dehydrogenase gsfK Antibody
Also known as Short chain dehydrogenase gsfK (Griseofulvin synthesis protein K).
Short chain dehydrogenase; part of the gene cluster that mediates the biosynthesis of griseofulvin, an important antifungal drug that has been in use for a long time for treating dermatophyte infections (PubMed:20534346, PubMed:23978092). The first step of the pathway is the formation of the heptaketide backbone by
>>>
gsfA which is initiated by priming with acetyl-CoA, followed by sequential condensations of 6 malonyl-CoA units (PubMed:20534346). O-methylation at 3-OH by gsfB leads to griseophenone D which is further methylated at 9-OH by gsfC to yield griseophenone C (PubMed:23978092). Griseophenone C is then substrate of halogenase gsfI which is responsible for the regio-specific chlorination at the C13 position to form griseophenone B (PubMed:23978092). The cytochrome P450 gsfF catalyzes the coupling of orcinol and phloroglucinol rings in griseophenone B to form desmethyl-dehydrogriseofulvin A which is further methylated at 5-OH by gsfD to yield dehydrogriseofulvin (PubMed:23978092). Finally, gsfE performs stereospecific reduction of enone 18 of dehydrogriseofulvin to afford the final product griseofulvin (PubMed:23978092). The exact role of gsfK within the pathway has not been identified yet (PubMed:23978092).
 gsfK ELISA Kit
 gsfK Recombinant
 gsfK Antibody
Table BarTOPTable Bar
 

Short chain dehydrogenase mdpC

 Short chain dehydrogenase mdpC ELISA Kit
 Short chain dehydrogenase mdpC Recombinant
 Short chain dehydrogenase mdpC Antibody
Also known as Short chain dehydrogenase mdpC (Monodictyphenone synthesis protein C).
Short chain dehydrogenase; part of the gene cluster that mediates the biosynthesis of monodictyphenone, a prenyl xanthone derivative (PubMed:20139316, PubMed:21351751). The pathway begins with the synthesis of atrochrysone thioester by the polyketide synthase (PKS) mdpG (PubMed:20139316). The atrochrysone carbo
>>>
xyl ACP thioesterase mdpF then breaks the thioester bond and releases the atrochrysone carboxylic acid from gedC (PubMed:20139316). The atrochrysone carboxylic acid is then converted to atrochrysone which is further transformed into emodin anthrone (PubMed:20139316). The next step is performed by the anthrone oxygenase mdpH that catalyzes the oxidation of emodinanthrone to emodin (). Emodin is further mofified to yield monodictyphenone via several steps involving by mdpB, mdpC mdpJ, mdpK and mdpL (PubMed:20139316, PubMed:21351751).
 mdpC ELISA Kit
 mdpC Recombinant
 mdpC Antibody
 AN0146 ELISA Kit
 AN0146 Recombinant
 AN0146 Antibody
Table BarTOPTable Bar
 

Short chain dehydrogenase sirQ

 Short chain dehydrogenase sirQ ELISA Kit
 Short chain dehydrogenase sirQ Recombinant
 Short chain dehydrogenase sirQ Antibody
Also known as Short chain dehydrogenase sirQ (Sirodesmin biosynthesis protein Q).
Short chain dehydrogenase; part of the gene cluster that mediates the biosynthesis of sirodesmin PL, an epipolythiodioxopiperazine (ETP) characterized by a disulfide bridged cyclic dipeptide and that acts as a phytotoxin which is involved in the blackleg didease of canola (PubMed:15387811, PubMed:18272357, PubMed:
>>>
19762440). SirD catalyzes the O-prenylation of L-tyrosine (L-Tyr) in the presence of dimethylallyl diphosphate (DMAPP) to yield 4-O-dimethylallyl-L-Tyr, and therefore represents probably the first pathway-specific enzyme in the biosynthesis of sirodesmin PL (PubMed:19762440, PubMed:21038099, PubMed:24083562). 4-O-dimethylallyl-L-Tyr, then undergoes condensation with L-Ser in a reaction catalyzed by the non-ribosomal peptide synthase sirP to form the diketopiperazine (DKP) backbone (PubMed:18272357). Further bishydroxylation of the DKP performed by the cytochrome P450 monooxygenase sirC leads to the production of the intermediate phomamide (PubMed:27390873). This step is essential to form the reactive thiol group required for toxicity of sirodesmin PL (PubMed:27390873). The next steps of sirodesmin biosynthesis are not well understood yet, but some predictions could be made from intermediate compounds identification (PubMed:18272357). Phomamide is converted into phomalizarine via oxidation, probably by sirT (PubMed:18272357). Further oxidation, methylation (by sirM or sirN) and reduction steps convert phomalizarine to deacetyl sirodesmin (PubMed:18272357). Finally, acetyltransferase sirH probably acetylates deacetyl sirodesmin to produce sirodesmin PL (PubMed:18272357).
 sirQ ELISA Kit
 sirQ Recombinant
 sirQ Antibody
Table BarTOPTable Bar
 

Short chain dehydrogenase sirR

 Short chain dehydrogenase sirR ELISA Kit
 Short chain dehydrogenase sirR Recombinant
 Short chain dehydrogenase sirR Antibody
Also known as Short chain dehydrogenase sirR (Sirodesmin biosynthesis protein R).
Short chain dehydrogenase; part of the gene cluster that mediates the biosynthesis of sirodesmin PL, an epipolythiodioxopiperazine (ETP) characterized by a disulfide bridged cyclic dipeptide and that acts as a phytotoxin which is involved in the blackleg didease of canola (PubMed:15387811, PubMed:18272357, PubMed:
>>>
19762440). SirD catalyzes the O-prenylation of L-tyrosine (L-Tyr) in the presence of dimethylallyl diphosphate (DMAPP) to yield 4-O-dimethylallyl-L-Tyr, and therefore represents probably the first pathway-specific enzyme in the biosynthesis of sirodesmin PL (PubMed:19762440, PubMed:21038099, PubMed:24083562). 4-O-dimethylallyl-L-Tyr, then undergoes condensation with L-Ser in a reaction catalyzed by the non-ribosomal peptide synthase sirP to form the diketopiperazine (DKP) backbone (PubMed:18272357). Further bishydroxylation of the DKP performed by the cytochrome P450 monooxygenase sirC leads to the production of the intermediate phomamide (PubMed:27390873). This step is essential to form the reactive thiol group required for toxicity of sirodesmin PL (PubMed:27390873). The next steps of sirodesmin biosynthesis are not well understood yet, but some predictions could be made from intermediate compounds identification (PubMed:18272357). Phomamide is converted into phomalizarine via oxidation, probably by sirT (PubMed:18272357). Further oxidation, methylation (by sirM or sirN) and reduction steps convert phomalizarine to deacetyl sirodesmin (PubMed:18272357). Finally, acetyltransferase sirH probably acetylates deacetyl sirodesmin to produce sirodesmin PL (PubMed:18272357).
 sirR ELISA Kit
 sirR Recombinant
 sirR Antibody
Table BarTOPTable Bar
 

Short chain dehydrogenase sirS

 Short chain dehydrogenase sirS ELISA Kit
 Short chain dehydrogenase sirS Recombinant
 Short chain dehydrogenase sirS Antibody
Also known as Short chain dehydrogenase sirS (Sirodesmin biosynthesis protein S).
Short chain dehydrogenase; part of the gene cluster that mediates the biosynthesis of sirodesmin PL, an epipolythiodioxopiperazine (ETP) characterized by a disulfide bridged cyclic dipeptide and that acts as a phytotoxin which is involved in the blackleg didease of canola (PubMed:15387811, PubMed:18272357, PubMed:
>>>
19762440). SirD catalyzes the O-prenylation of L-tyrosine (L-Tyr) in the presence of dimethylallyl diphosphate (DMAPP) to yield 4-O-dimethylallyl-L-Tyr, and therefore represents probably the first pathway-specific enzyme in the biosynthesis of sirodesmin PL (PubMed:19762440, PubMed:21038099, PubMed:24083562). 4-O-dimethylallyl-L-Tyr, then undergoes condensation with L-Ser in a reaction catalyzed by the non-ribosomal peptide synthase sirP to form the diketopiperazine (DKP) backbone (PubMed:18272357). Further bishydroxylation of the DKP performed by the cytochrome P450 monooxygenase sirC leads to the production of the intermediate phomamide (PubMed:27390873). This step is essential to form the reactive thiol group required for toxicity of sirodesmin PL (PubMed:27390873). The next steps of sirodesmin biosynthesis are not well understood yet, but some predictions could be made from intermediate compounds identification (PubMed:18272357). Phomamide is converted into phomalizarine via oxidation, probably by sirT (PubMed:18272357). Further oxidation, methylation (by sirM or sirN) and reduction steps convert phomalizarine to deacetyl sirodesmin (PubMed:18272357). Finally, acetyltransferase sirH probably acetylates deacetyl sirodesmin to produce sirodesmin PL (PubMed:18272357).
 sirS ELISA Kit
 sirS Recombinant
 sirS Antibody
Table BarTOPTable Bar
 

Short chain dehydrogenase trt9

 Short chain dehydrogenase trt9 ELISA Kit
 Short chain dehydrogenase trt9 Recombinant
 Short chain dehydrogenase trt9 Antibody
Also known as Short chain dehydrogenase trt9 (Terretonin synthesis protein 9).
Short chain dehydrogenase; part of the gene cluster that mediates the biosynthesis of terretonin, a fungal meroterpenoid that acts as a mycotoxin (PubMed:22549923, PubMed:23116177, PubMed:25671343). The first step of the pathway is the synthesis of 3,5-dimethylorsellinic acid (DMOA) by the polyketide synthase trt4 (P
>>>
ubMed:22549923, PubMed:23116177). DMOA is then prenylated into farnesyl-DMOA by the polyprenyl transferase trt2 (PubMed:22549923, PubMed:22782788, PubMed:23116177). Methylation by the methyltransferase trt5 then leads to farnesyl-DMOA methyl ester which is further subject to epoxidation by the FAD-dependent monooxygenase trt8 to yield epoxyfarnesyl-DMOA methyl ester (PubMed:22549923, PubMed:22782788, PubMed:23116177). Cyclization of epoxyfarnesyl-DMOA methyl ester by the terpene cyclase trt1 leads to a tetracycle intermediate which is in turn converted to preterretonin (PubMed:22549923, PubMed:22782788, PubMed:23116177). Dehydrogenase trt9 comes next to transform preterretonin to preterrenoid (PubMed:22549923, PubMed:23116177). The FAD-dependent monooxygenase trt3 is then required for the C-hydroxylation at C16 of preterrenoid to yield terrenoid (PubMed:22549923, PubMed:23116177). The cytochrome P450 trt6 catalyzes three successive oxidations to transform terrenoid into an unstable intermediate, which then undergoes the D-ring expansion and unusual rearrangement of the methoxy group to afford the core skeleton of terretonin (PubMed:25671343). This unprecedented rearrangement is catalyzed by the isomerase trt14 (PubMed:25671343). Finally, the nonheme iron-dependent dioxygenase trt7 accomplishes the last two oxidation reactions steps to complete the biosynthesis of terretonin (PubMed:25671343). Terretonin C is produced via spontaneous decarboxylation of the terretonin precursor (PubMed:23116177). Another shunt product of the terretonin biosynthesis is dihydrofarnesyl-DMOA, derived from epoxyfarnesyl-DMOA through hydrolysis of the epoxide (PubMed:22549923, PubMed:22782788, PubMed:23116177).
 trt9 ELISA Kit
 trt9 Recombinant
 trt9 Antibody
 ATEG_10086 ELISA Kit
 ATEG_10086 Recombinant
 ATEG_10086 Antibody
Table BarTOPTable Bar
 

Short chain dehydrogenase yanD

 Short chain dehydrogenase yanD ELISA Kit
 Short chain dehydrogenase yanD Recombinant
 Short chain dehydrogenase yanD Antibody
Also known as Short chain dehydrogenase yanD (Yanuthone D synthesis protein D).
Short chain dehydrogenase; part of the gene cluster that mediates the biosynthesis of yanuthone D, a fungal isoprenoid epoxycyclohexenone that acts as an antibiotic against fungi and bacteria (PubMed:24684908). The first step of the pathway is the synthesis of 6-methylsalicylic acid (6-MSA) by the polyketide synthas
>>>
e yanA (PubMed:24684908). 6-MSA is then converted to m-cresol by the decarboxylase yanB (PubMed:24684908). The cytochrome P450 monooxygenase yanC then catalyzes the oxidation of m-cresol to toluquinol (PubMed:24684908). Epoxidation of toluquinol is then performed by the short chain dehydrogenase yanD, with the help of yanE, and a further prenylation by yanG leads to 7-deacetoxyyanuthone A (PubMed:24684908). The next step is the hydroxylation of C-22 of 7-deacetoxyyanuthone A by the cytochrome P450 monooxygenase yanH to yield 22-deacetylyanuthone A (PubMed:24684908). O-Mevalon transferase yanI then attaches mevalon to the hydroxyl group of 22-deacetylyanuthone A to produce yanuthone E (PubMed:24684908). Finally, the FAD-dependent monooxygenase yanF oxidizes the hydroxyl group at C15 of yanuthone E to form yanuthone D (PubMed:24684908). Furthermore, several branching points in the pathway lead to the production of yanuthones F and G from 7-deacetoxyyanuthone A; yanuthones H and I from 22-deacetylyanuthone A; and yanuthone J from yanuthone E (PubMed:24684908). YanD is also involved in the synthesis of yanuthone X1 which does not have 6-methylsalicylic acid (6-MSA) as precurdor (PubMed:24684908).
 yanD ELISA Kit
 yanD Recombinant
 yanD Antibody
 ASPNIDRAFT_127904 ELISA Kit
 ASPNIDRAFT_127904 Recombinant
 ASPNIDRAFT_127904 Antibody
Table BarTOPTable Bar
 

Short-chain dehydrogenase TIC 32

 Short-chain dehydrogenase TIC 32 ELISA Kit
 Short-chain dehydrogenase TIC 32 Recombinant
 Short-chain dehydrogenase TIC 32 Antibody
Also known as Short-chain dehydrogenase TIC 32, chloroplastic (Translocon at the inner envelope membrane of chloroplasts 32) (AtTIC32).
Involved in protein precursor import into chloroplasts. Part of the redox regulon consisting of TIC32, TIC 55 and TIC62.
 TIC32 ELISA Kit
 TIC32 Recombinant
 TIC32 Antibody
 At4g23430 ELISA Kit
 At4g23430 Recombinant
 At4g23430 Antibody
 F16G20.130 ELISA Kit
 F16G20.130 Recombinant
 F16G20.130 Antibody
Table BarTOPTable Bar
Proteins Root Name Listing
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions